Related Experiment Video
Updated: Sep 21, 2025
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
Farah Omran1,2,3, Ioannis Kyrou1,2,4,5,6, Faizel Osman1,7
1Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
Insights
Early detection of cardiovascular diseases (CVDs) is crucial. This review examines historical, current, and future cardiac biomarkers for CVD diagnosis, highlighting their limitations and the need for improved detection methods.
Area of Science:
- Biomedical science
- Clinical diagnostics
Background:
- Cardiovascular diseases (CVDs) represent a significant global health challenge.
- Early detection of CVDs is vital for effective prevention and treatment, reducing morbidity and mortality.
- Biomarkers are essential tools for diagnosing, screening, and providing prognostic information for cardiovascular conditions.
Purpose of the Study:
- To review the evolution of cardiac biomarkers for CVD detection.
- To discuss the applications and limitations of historical and current biomarkers.
- To explore the potential of future biomarkers and the challenges for their clinical adoption.
Main Methods:
- Literature review of historical and contemporary cardiac biomarkers.
- Analysis of biomarker applications in clinical practice.
- Evaluation of emerging biomarkers and their potential impact.
Main Results:
- Historical biomarkers have been largely superseded by newer ones in routine clinical practice.
- Current biomarkers improve CVD detection but do not identify all cases.
- Future biomarkers show promise but require further validation and established analytical platforms.
Conclusions:
- Ongoing research aims to enhance CVD detection through novel biomarkers.
- Clinical implementation of new biomarkers depends on demonstrating superior diagnostic or prognostic value.
- Defining the specific role (diagnostic, prognostic, screening) of new biomarkers is critical for healthcare integration.
Abstract:
Cardiovascular diseases (CVDs) are a major healthcare burden on the population worldwide. Early detection of this disease is important in prevention and treatment to minimise morbidity and mortality. Biomarkers are a critical tool to either diagnose, screen, or provide prognostic information for pathological conditions. This review discusses the historical cardiac biomarkers used to detect these conditions, discussing their application and their limitations. Identification of new biomarkers have since replaced these and are now in use in routine clinical practice, but still do not detect all disease. Future cardiac biomarkers are showing promise in early studies, but further studies are required to show their value in improving detection of CVD above the current biomarkers. Additionally, the analytical platforms that would allow them to be adopted in healthcare are yet to be established. There is also the need to identify whether these biomarkers can be used for diagnostic, prognostic, or screening purposes, which will impact their implementation in routine clinical practice.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:30Coronary Artery Disease I: Introduction
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:26Coronary Artery Disease IV: Preventive Measures